Germany· DE-A57-41a7774940620b2b

Rabeprazol Tad

A rabeprazole product containing rabeprazole sodium, registered in Germany by Tad Pharma Gmbh. The same ATC class is registered in 17 of our 19 countries.

ATC A02BC04

Checked against EMA Article 57 (European Union) on September 30, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about rabeprazole sodiumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Rabeprazole is registered in 17 of 19 countries.

Countries holding a registration under ATC A02BC04 (rabeprazole), each read from that country’s own register.

This record: Germany, from EMA Article 57 (European Union)
10 of them publish a price we can compare per daily dose

Search rabeprazole products by name

Rabeprazole · ATC A02BC04

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Polandprice
Spainprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rabeprazole costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.13 in France to $0.85 in Switzerland — a ×6.4 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Rabeprazole · price per daily dose (10 mg)

USD · FX 28 Sept 2026

CH Switzerland$0.85
ES Spain$0.50
IT Italy$0.24
FR France$0.13

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)

Active substance: Rabeprazole Sodium
Manufacturer: Tad Pharma Gmbh
Country: Germany (DE)
ATC code: A02BC04
ATC class: Rabeprazole
Defined daily dose: 10 mg, O
Reimbursed: Not published by this register
Source register: EMA Article 57 (European Union)
Last checked: September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

592 interactions on record for rabeprazole.

Graded by severity as the source publishes them — 22 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check rabeprazole against other medicines How interaction checks work

Rabeprazole · interactions on record

592 records

22 severe
107 moderate
27 minor
427 info

Most severe, free to view

ClopidogrelB01AC04severe
NelfinavirJ05AE04severe
AtazanavirJ05AE08severe
RilpivirineJ05AG05severe

9 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rabeprazole in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rabeprazole products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Pariet, Rabeprazol 1a Pharma
Belgium · Pariet
Bulgaria · Ацилесол, Зулбекс
Cyprus · Pariet, Rabeprazole Krka
Czechia · Rapoxol, Zulbex
Denmark · Pariet, Rabeprazol Medical Valley
Estonia · Rabeprazole Actavis, Rabeprazole Doc Generici
Spain · Pariet, Rabeprazol Almus
Finland · Pariet, Rabeprazol Krka
France · Pariet, Rabeprazole Almus
United Kingdom (Northern Ireland) · Pariet, Rabeprazole Accord Healthcare
Greece · Aircodos, Berlex
Croatia · Ares, Zulbex
Hungary · Acilesol, Gelbra
Ireland · Pariet, Rabeprazole Krka
Iceland · Pariet, Rabeprazol Actavis
Italy · Akirab, Pariet
Lithuania · Rabeprazole Actavis, Yzilan
Luxembourg · Pariet
Latvia · Rabeprazole Adoh, Zulbex
Malta · Pariet
Netherlands · Beryx, Pariet
Poland · Zulbex
Portugal · Pariet, Rabeprazol Aurovitas
Romania · Relitaz, Zulbex
Sweden · Pariet
Slovenia · Rabeprazol Lek, Zulbex
Slovakia · Zulbex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/da55c8e0-676f-4f03-b580-a38a877f93aa
GET /v1/drugs/da55c8e0-676f-4f03-b580-a38a877f93aa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Rabeprazole Sodium",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

API reference MCP server Plans

See everything about rabeprazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console